Hubertus von Baumbach

Hubertus von Baumbach (born 1967) is a German businessman who is the chairman and CEO of Boehringer Ingelheim, Germany's second largest pharmaceutical company.^[2]

Hubertus von Baumbach
Born	1966 or 1967 (age 57–58)[1]
Nationality	German
Occupation	Businessman
Title	Chairman and CEO, Boehringer Ingelheim

Early life and education

The son of Erich von Baumbach and Ulrike Boehringer, Hubertus von Baumbach is also a great-grandson of the company's founder Albert Boehringer.^[1]

Career

Baumbach joined Boehringer Ingelheim in 2001.^[3]

In November 2015, it was announced that Baumbach, who had been CFO, was appointed as chief executive, succeeding Andreas Barner in June 2016.^[1][2] At the time, this made him the first member of the family at the helm in 25 years.^[4] Within his first six months, he launched the biggest acquisition in the company's history (an asset swap deal with French rival Sanofi), followed by a reorganization to give the group a more decentralized divisional structure.^[5]

In his capacity at Boehringer Ingelheim, Baumbach was part of Chancellor Angela Merkel’s delegation on three state visits to China.^[6]

Other activities

Corporate boards

• Deutsche Bank, Member of the Advisory Board^[7]
• Baden-Württembergische Bank, Member of the Advisory Board
• Landesbank Baden-Württemberg (LBBW), Member of the Advisory Board^[8]
• KWS Saat, Member of the supervisory board (2007-2017)

Non-profit organizations

• Federation of German Industries (BDI), Member of the Presidium (2018-2019)^[9]
• German Chemical Industry Association (VCI), Member of the Executive Committee^[10]
• Baden-Badener Unternehmer-Gespräche (BBUG), Member of the Board of Trustees^[11]
• Cultural Foundation of the Federal States, Member of the Board of Trustees^[12]
• Städel Museum, Member of the Administration^[13] and the Board of Trustees^[14]
• Stiftung Tausendgut, Member of the Board of Trustees^[15]